Other languages CV Sciences, Inc.

Equities

CVSI

US1266541028

Market Closed - OTC Markets Other stock markets 03:59:54 2024-04-15 pm EDT			5-day change	1st Jan Change
0.0373 ^USD	-1.95%		-1.84%	+5.37%

Mar. 28	Transcript : CV Sciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024
Mar. 28	CV Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CV Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28
CV Sciences, Inc. Expands +PlusCBD Pet Product Offerings with the Launch of Pet Chews	Mar. 26
CV Sciences, Inc. acquired Cultured Foods Sp. z.o.o for $0.535 million.	Dec. 11
CV Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14
CV Sciences, Inc. Launches Reserve Sleep Gummies	23-09-05
CV Sciences, Inc. Seeks Acquisitions	23-08-14
CV Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
CV Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15
CV Sciences Seeks M&A Opportunities	23-05-15
CV Sciences, Inc. Auditor Raises 'Going Concern' Doubt	23-03-29
CV Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-29
CV Sciences, Inc. Receives Formal Notice of Patent Issuance from Japan Patent Office for Formulations Containing Cannabidiol and Nicotine for Treating Smokeless Tobacco Addiction	23-03-23
CV Sciences, Inc. Launches New Line of THC-Free Gummies and Softgels	23-03-21
CV Sciences, Inc. Launches 30-Count of Popular +PlusCBD Reserve Collection Softgels	23-01-18
CV Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14
CV Sciences, Inc. Appoints William McCorkle as Director	22-10-25
Sector Update: Financial	22-08-22
CV Sciences, Inc. Announces Launch of PlusCBD Reserve Collection Softgels	22-08-15
CV Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15
CV Sciences, Inc. Appoints Jamie Corroon as Director	22-07-27

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages CV Sciences, Inc.

Equities

CVSI

US1266541028

Other languages

Filters